Welcome to our dedicated page for Microvision SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MicroVision, Inc. (NASDAQ: MVIS) SEC filings, offering a centralized view of the company’s regulatory disclosures. Through these documents, investors can review how MicroVision reports on its lidar hardware and perception software business, its activities in automotive, industrial, and defense-related markets, and its corporate governance and financing arrangements.
Key filings for MicroVision include Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s business, risk factors, and financial results. These reports are particularly relevant for understanding MicroVision’s investment in solid-state lidar technologies, its focus on ADAS and autonomous driving, and its efforts in industrial automation and defense tech. Current reports on Form 8-K provide timely updates on material events, such as leadership changes, executive compensation arrangements, board appointments, and the announcement of quarterly results.
MicroVision’s filings also document corporate actions like the appointment of a new Chief Executive Officer, the designation of an Executive Vice Chair, changes in board composition, and transitions in the Chief Financial Officer role. These disclosures help investors track how the company’s leadership and governance structure evolve alongside its strategic focus on autonomy and mobility.
On Stock Titan, MicroVision’s SEC documents are updated in near real time as they are posted to EDGAR. AI-powered summaries assist readers by highlighting the main points in lengthy filings, including key business updates, segment information where provided, and notable risk or governance items. Users can quickly scan 10-K and 10-Q reports, review 8-K announcements about material events, and access other filings while relying on AI-generated explanations to navigate complex regulatory language more efficiently.
MicroVision, Inc. registers up to 61,315,970 shares of common stock underlying senior secured convertible notes due 2028 (the "Convertible Notes"). These Shares are issuable upon conversion of the Convertible Notes and are being registered for resale by the selling stockholders.
The company will receive no proceeds from sales by the selling stockholders. The prospectus discloses 326,982,727 shares outstanding as of April 20, 2026 and states a pro forma figure of 388,298,697 common shares outstanding assuming all Shares offered herein are issued pursuant to conversion of the Convertible Notes.
MicroVision, Inc. filed an amended report to provide full financial details for its acquisition of Luminar Technologies’ LiDAR sensor business. MicroVision completed the asset purchase on February 3, 2026 under a January 26, 2026 agreement and paid total cash consideration of $33.2 million, including cure costs.
The filing adds audited carved‑out financials for the Luminar LiDAR Business and unaudited pro forma results. The acquired business generated $40.976 million of revenue in 2025 but reported a net loss of $280.7 million, following a $396.0 million loss in 2024. Its 2025 results include a $42.8 million loss on firm purchase commitments and $21.7 million of restructuring and other costs.
The auditor’s report highlights substantial doubt about the Luminar LiDAR Business’s ability to continue as a going concern due to the Parent’s recurring losses and Chapter 11 bankruptcy. As of December 31, 2025, $78.4 million of pre‑petition obligations were classified as liabilities subject to compromise, and reorganization items of $3.5 million were recorded in 2025.
MicroVision Interim CFO Stephen Hrynewich reported routine equity compensation activity. On April 6, 2026, vested restricted stock units (RSUs) converted into 4,800 shares of common stock on a unit-for-share basis, without cash payment.
On April 8, 2026, the company completed a tax-related, nondiscretionary sell-to-cover transaction, withholding 1,555 shares of common stock at a weighted average price of $0.6289 per share to satisfy tax obligations under the award agreement. Following these transactions, Hrynewich directly owns 175,337 shares of MicroVision common stock.
MicroVision, Inc. furnished a new investor presentation under Regulation FD. The presentation, dated April 2026, is available on the company’s investor relations website and is attached as Exhibit 99.1. MicroVision expects to use this deck, in whole or in part, in presentations to investors, analysts and others throughout 2026.
The company states that the information in the presentation is summary in nature and should be read together with its SEC filings and other public announcements. The material is being furnished, not filed, so it is not subject to certain Exchange Act liabilities and will not be automatically incorporated into Securities Act registration statements.
MICROVISION, INC. CEO Glen W. DeVos reported routine equity compensation activity involving restricted stock units and related tax withholding. On March 31, 2026, 325,000 vested restricted stock units converted into an equal number of common shares. On April 2, 2026, the company completed a tax-related nondiscretionary sell-to-cover transaction, withholding 153,230 common shares at a weighted average price of $0.6403 per share in multiple trades between $0.6402 and $0.6408. Following these transactions, DeVos directly holds 359,670 shares of MicroVision common stock. The filing reflects compensation vesting and tax settlement rather than open-market buying or selling by the CEO.
The Vanguard Group filed Amendment No. 3 to Schedule 13G/A reporting 0 shares of MicroVision Inc. common stock as beneficially owned. The filing explains an internal realignment and disaggregation under SEC Release No. 34-39538 (January 12, 1998), with certain subsidiaries reporting separately. The amendment is signed by Ashley Grim on 03/27/2026.
MicroVision, Inc. Executive Vice Chair Simon Biddiscombe acquired 93,950 shares of the company’s common stock on March 15, 2026. The shares were purchased directly from MicroVision under a Subscription Agreement at $0.5322 per share, the closing price on March 13, 2026, in a transaction intended to be exempt under Rule 16b-3. Following this acquisition, Biddiscombe directly holds 385,249 MicroVision shares.
MicroVision director Jeffrey A. Herbst acquired 28,185 shares of common stock directly from the company at $0.5322 per share under a Subscription Agreement executed on March 15, 2026. The purchase price matched the closing share price on March 13, 2026 and is intended to qualify as an exempt transaction under Rule 16b-3. Following this acquisition, Herbst directly holds 258,912 shares of MicroVision common stock.
MicroVision director Robert Paul Carlile acquired additional shares of the company’s common stock. On March 15, he obtained 187,900 shares directly from MicroVision under a Subscription Agreement at $0.5322 per share, matching the March 13 closing price. This increased his direct holdings to 538,699 shares. The purchase is intended to qualify as an exempt transaction under Rule 16b-3, meaning it is structured within specific insider trading exemption rules rather than as an open-market trade.
MicroVision director Laura J. Peterson acquired 37,580 shares of common stock from the company under a subscription agreement. The shares were purchased directly from MicroVision at a price of $0.5322 per share, matching the closing price on March 13, 2026.
After this exempt Rule 16b-3 transaction, Peterson directly holds 91,596 MicroVision shares. This reflects a compensation-related or insider-aligned acquisition rather than an open-market trade.